{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:00:19Z","timestamp":1781197219629,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007292","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.toxlet.2020.01.021","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:31:30Z","timestamp":1579779090000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica"],"prefix":"10.1016","volume":"323","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-4652","authenticated-orcid":false,"given":"Aizhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-2855","authenticated-orcid":false,"given":"Zhengtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2020.01.021_bib0005","volume":"Vol I","author":"Chinese Pharmacopoeia Commission","year":"2015"},{"issue":"5","key":"10.1016\/j.toxlet.2020.01.021_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0041-0101(95)00169-7","article-title":"A simple procedure for determining the aqueous half-lives of pyrrolic metabolites of pyrrolizidine alkaloids","volume":"34","author":"Cooper","year":"1996","journal-title":"Toxicon."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0015","first-page":"13","article-title":"The relationship between reactivity of metabolites of pyrrolizidine alkaloids and extrahepatic toxicity","volume":"42","author":"Cooper","year":"1999","journal-title":"Proc. West. Pharmacol. Soc."},{"issue":"9","key":"10.1016\/j.toxlet.2020.01.021_bib0020","first-page":"1627","article-title":"Expert consensus on diagnosis and treatment of pyrrolidine alkaloids-related sinusoidal obstruction syndrome","volume":"33","author":"Cooperative Group for Hepatic and Gall Diseases","year":"2017","journal-title":"J Clin Hepatol."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0025","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3748\/wjg.v13.i10.1628","article-title":"Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature","volume":"13","author":"Dai","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.toxlet.2020.01.021_bib0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"15","key":"10.1016\/j.toxlet.2020.01.021_bib0040","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jssc.201400314","article-title":"Mass-spectrometry-directed analysis and purification of pyrrolizidine alkaloid cis\/trans isomers in Gynura japonica","volume":"37","author":"Fang","year":"2014","journal-title":"J. Sep. Sci."},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab. Rev."},{"issue":"9","key":"10.1016\/j.toxlet.2020.01.021_bib0050","first-page":"979","article-title":"Evidence-based clinical study of pyrrolizidine alkaloids associated with hepatic sinusoidal obstruction syndrome","volume":"27","author":"Gao","year":"2018","journal-title":"Chin J Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1751-2980.2011.00552.x","article-title":"Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids","volume":"13","author":"Gao","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0060","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.2147\/DDDT.S87858","article-title":"Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome","volume":"9","author":"Gao","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0065","series-title":"Bundesanzeiger. June 17, 4805. Dtsch. Apoth. Ztg","author":"German Federal Health Bureau","year":"1992"},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0070","first-page":"1277","article-title":"Clinical features of sinusoidal obstruction syndrome induced by pyrrolidine alkaloids in China","volume":"34","author":"Guo","year":"2018","journal-title":"J Clin Hepatol."},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0080","first-page":"196","article-title":"Research and prospect of sinusoidal obstruction syndrome caused by Gynura Segetum","volume":"4","author":"Hu","year":"2019","journal-title":"J Syst Med."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0085","first-page":"109","article-title":"Relationship between in vitro metabolism of pyrrolizidine alkaloids and extrahepatic toxicity in vivo","volume":"37","author":"Huxtable","year":"1994","journal-title":"Proc. West. Pharmacol. Soc."},{"issue":"2","key":"10.1016\/j.toxlet.2020.01.021_bib0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02529131","article-title":"Physicochemical and metabolic basis for the differing neurotoxicity of the pyrrolizidine alkaloids, trichodesmine and monocrotaline","volume":"21","author":"Huxtable","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0095","series-title":"Pyrrolizidine Alkaloids Health and Safety Guide","author":"International Programme on Chemical Safety","year":"1989"},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.etp.2007.11.010","article-title":"The toxic effect of pyrrolizidine alkaloid clivorine on the human embryonic kidney 293 cells and its primary mechanism","volume":"60","author":"Ji","year":"2008","journal-title":"Exp. Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0105","first-page":"540","article-title":"Progress in the pathogenesis, clinical diagnosis and treatment of hepatic sinus obstruction syndrome caused by tusanqi","volume":"23","author":"Li","year":"2018","journal-title":"Chin Hepatol."},{"issue":"9","key":"10.1016\/j.toxlet.2020.01.021_bib0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/138920011797470119","article-title":"Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs","volume":"12","author":"Li","year":"2011","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/np9906119","article-title":"Characterization of two structural forms of otonecine-type pyrrolizidine alkaloids from Ligularia hodgsonii by NMR spectroscopy","volume":"63","author":"Lin","year":"2000","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.toxlet.2020.01.021_bib0120","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.toxlet.2020.01.021_bib0125","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1007\/s00204-018-2309-6","article-title":"The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity","volume":"92","author":"Lu","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.toxlet.2020.01.021_bib0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jfda.2018.05.005","article-title":"Pyrrole-protein adducts: a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity","volume":"26","author":"Ma","year":"2018","journal-title":"J. Food Drug Anal."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0135","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.chemrestox.8b00369","article-title":"Pyrrole-hemoglobin adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure","volume":"2","author":"Ma","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijms19061668","article-title":"Pyrrolizidine alkaloids: chemistry, pharmacology, toxicology and food safety","volume":"19","author":"Moreira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.toxlet.2020.01.021_bib0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.18433\/J3BG7J","article-title":"Hepatotoxicity of pyrrolizidine alkaloids","volume":"18","author":"Neuman","year":"2015","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.toxlet.2020.01.021_bib0150","first-page":"548","article-title":"Clinical analysis of 5 cases of hepatic sinus obstruction syndrome caused by tusanqi","volume":"27","author":"Qi","year":"2019","journal-title":"Chin J Integr Trad West Med Dig."},{"issue":"6","key":"10.1016\/j.toxlet.2020.01.021_bib0155","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/tx500071q","article-title":"Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis","volume":"27","author":"Ruan","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2020.01.021_bib0160","first-page":"404","article-title":"Blood pyrrole-protein adducts-A biomarker of pyrrolizidine alkaloid-induced liver injury in humans","volume":"33","author":"Ruan","year":"2015","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"issue":"7","key":"10.1016\/j.toxlet.2020.01.021_bib0165","first-page":"762","article-title":"Pyrrolizidine alkaloids-containing Chinese medicines in the Chinese pharmacopoeia and related safety concerns","volume":"46","author":"Tang","year":"2011","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/ijerph2005010074","article-title":"Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo","volume":"2","author":"Wang","year":"2005","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"4","key":"10.1016\/j.toxlet.2020.01.021_bib0175","first-page":"362","article-title":"Metabolic activation of pyrrolizidine alkaloids leading to phototoxicity and photogenotoxicity in human HaCaT keratinocytes","volume":"32","author":"Wang","year":"2014","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"issue":"23","key":"10.1016\/j.toxlet.2020.01.021_bib0180","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1097\/MD.0000000000000942","article-title":"Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine."},{"issue":"3","key":"10.1016\/j.toxlet.2020.01.021_bib0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/19440049.2010.541288","article-title":"Plants containing pyrrolizidine alkaloids: toxicity and problems","volume":"28","author":"Wiedenfeld","year":"2011","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.toxlet.2020.01.021_bib0190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","article-title":"Senecio disease or cirrhosis of the liver due to Senecio poisoning","volume":"2","author":"Willmot","year":"1920","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.toxlet.2020.01.021_bib0195","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.phymed.2016.06.006","article-title":"Clivorine, an otonecine pyrrolizidine alkaloid from Ligularia species, impairs neuronal differentiation via NGF-induced signaling pathway in cultured PC12 cells","volume":"23","author":"Xiong","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.toxlet.2020.01.021_bib0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phymed.2018.06.015","article-title":"Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice","volume":"54","author":"Xiong","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.toxlet.2020.01.021_bib0205","series-title":"Standards of Yunnan Food and Drug Administration","author":"Yunnan Food and Drug Administration","year":"2005"},{"issue":"1","key":"10.1016\/j.toxlet.2020.01.021_bib0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aca.2007.10.021","article-title":"Quantitative analysis of total retronecine esters-type pyrrolizidine alkaloids in plant by high performance liquid chromatography","volume":"605","author":"Zhang","year":"2007","journal-title":"Anal. Chim. Acta"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427420300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427420300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:18:20Z","timestamp":1759900700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427420300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":42,"alternative-id":["S0378427420300291"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2020.01.021","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2020.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}